The global biological therapy market size was valued at USD 500.17 billion in 2025and is expected to reach USD 1,020.26 billion by 2033, at a CAGR of 9.32% during the forecast period
The market growth is primarily driven by the increasing adoption of advanced biologics such as monoclonal antibodies, recombinant proteins, and cell & gene therapies, along with continuous innovation in precision medicine and targeted treatment approaches across chronic and life-threatening diseases
Furthermore, rising prevalence of cancer, autoimmune disorders, and inflammatory diseases, coupled with growing investment in biopharmaceutical R&D and expanding regulatory approvals for novel biologic drugs, is strengthening the shift toward biologics as a preferred therapeutic option, thereby significantly accelerating market expansion